Daily digest · Sun · 11 Oct 2026

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

Early cancer detection

PMID42858727 · Immunotherapy and circulating tumor DNA in HPV-positive oropharyngeal cancer: a · 7/10 · The three studies contributing immunotherapy-associated estimates (k = 3, n = 126) showed no benefit (PFS HR, 0.96; 95%

Novel therapeutics: immunotherapy CAR-T targeted therapy

PMID42855739 · First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI- · 7/10 · CONCLUSION: BPI-460,372 demonstrated a distinct pharmacokinetic profile and showed preliminary antitumor activity in pat

🟢⚪ STANDARD (5-7) — Top by Topic

Hematologic malignancies

PMID42858267 · Clinical Features and Prognostic Impact of Splicing Factor Mutations and Their C · 6/10 · Treatment Innovation
PMID42856044 · From oncogenesis to approval: the lentiviral gene therapy revolution in Wiskott- · 6/10 · Drug Development
PMID42857718 · Influence of gut microbiota on chronic lymphocytic leukemia development and aggr · 5/10 · Treatment Innovation
PMID42858312 · Peripheral CD4(+) T-Cell Reserve as a Potential Biomarker of CD20 × CD3 Bispecif · 5/10 · Treatment Innovation
PMID42858931 · Infectious complications of treatment for acute lymphoblastic leukemia in adults · 5/10 · Treatment Innovation

CBC-based diagnostics and ML in hematology

PMID42858729 · Belgian validation of the INFLUENCE 3.0 model predicting 5-year locoregional and · 5/10 · Diagnostics

Early cancer detection

PMID42855731 · Exploratory Analysis of Circulating miR-486-3p and miR-21-5p in Early Detection · 6/10 · Early Detection
PMID42858234 · Fanconi anemia pathway disruption drives lomustine sensitivity in glioma. · 5/10 · Early Detection
PMID42858606 · Convergent molecular evidence identifies a robust seven-gene signature in esopha · 5/10 · Early Detection
PMID42858308 · Tissue-Specific Isolation of Hepatocyte Extracellular Vesicles From Human Plasma · 5/10 · Early Detection
PMID42855963 · Associations of Serum Per- and Polyfluoroalkyl Substances (PFAS) With Epigenetic · 5/10 · Early Detection

AI/ML in clinical diagnostics and imaging

PMID42857616 · LLM-supported self-diagnosis and self-treatment of familial Mediterranean fever: · 7/10 · Diagnostics
PMID42858288 · Machine Learning for Predicting Dental Caries Presence and Severity: An Age-Coho · 7/10 · Diagnostics
PMID42859098 · Utility of OpenEvidence and ChatGPT in Selecting Neuroimaging Based on Appropria · 6/10 · Diagnostics
PMID42857094 · Deep Learning-Derived Retinal Vascular Morphology and Incident Treatment for Sig · 5/10 · Diagnostics
PMID42855788 · [Clinical applications and future perspectives of ultra-widefield swept-source o · 5/10 · Diagnostics

Precision oncology and genomic medicine

PMID42858230 · Cost-effectiveness of amivantamab plus lazertinib and osimertinib plus chemother · 6/10 · Genomics/Precision Medicine
PMID42858163 · Biomarker-guided immunotherapies for primary CNS tumors. · 6/10 · Treatment Innovation
PMID42857877 · Giant Cell Glioblastoma: Case Series of a Rare Glioma with Unique Histomorpholog · 5/10 · Genomics/Precision Medicine
PMID42857319 · Research progress of pancreatic cancer based on ferroptosis-cuproptosis interact · 5/10 · Genomics/Precision Medicine
PMID42856906 · KRT14 activated by transcription factor E2F1 promotes bladder cancer progression · 5/10 · Genomics/Precision Medicine

Novel therapeutics: immunotherapy CAR-T targeted therapy

PMID42858728 · Prognostic implications of asymptomatic COVID-19 infection in non-small-cell lun · 5/10 · Treatment Innovation
PMID42856446 · Functional Exhaustion Limits CAR-NK Therapy in Glioblastoma but Can Be Mitigated · 5/10 · Treatment Innovation
PMID42856609 · Early dynamics of a neutrophil interferon program drive immunotherapy resistance · 5/10 · Treatment Innovation
PMID42858139 · Real-world efficacy and safety of neoadjuvant immunochemotherapy in patients wit · 4/10 · Treatment Innovation
PMID42856090 · Topological Engineering of NIR-II Emissive Conjugated Oligomers With Unexpected · 4/10 · Treatment Innovation

Cardiovascular-metabolic: GLP-1 SGLT2 cardiometabolic risk

PMID42857180 · Real-world treatment-transition pathways and dosing patterns of insulin degludec · 7/10 · Treatment Innovation
PMID42856082 · Lipoprotein(a)-dependent cardiovascular risk in different populations: are thres · 7/10 · Treatment Innovation
PMID42857821 · Novel Siphon Tube Technique in the Surgical Evacuation of Chronic Subdural Hemat · 6/10 · Treatment Innovation
PMID42856750 · Trends and projected burden of ischemic heart disease mortality with co-document · 6/10 · Treatment Innovation
PMID42857114 · Translating mechanobiology in osteoarthritis to biomaterial-informed therapeutic · 5/10 · Treatment Innovation

Aging longevity and population health

PMID42858449 · Does COVID-19 Vaccination Protect Against Post-COVID Cardiovascular Conditions? · 6/10 · Public Health
PMID42855777 · [Chinese expert consensus on high-dose anti-vascular endothelial growth factor t · 6/10 · Public Health
PMID42858075 · Digital Interventions for Frailty and Pelvic Floor Dysfunction in Older Adults: · 6/10 · Public Health
PMID42857210 · Mechanisms and Application Strategies of Flavonoid Active Compounds in the Treat · 6/10 · Public Health
PMID42856094 · Attack severity in hereditary angioedema: a qualitative study to inform future e · 5/10 · Public Health

Rare diseases with high unmet need

PMID42859078 · Perspectives on inhaled medicines in the CFTR modulator era: A national survey o · 6/10 · Drug Development
PMID42857968 · Managing growth and puberty concerns in individuals with Duchenne muscular dystr · 6/10 · Drug Development
PMID42858672 · Sterility testing in the era of decentralised cell therapy: Challenges, innovati · 5/10 · Drug Development
PMID42858164 · Prognostication in Amyotrophic Lateral Sclerosis: A Narrative Review of Pre-Diag · 5/10 · Drug Development
PMID42855884 · Five decades of gene therapy innovation and regulation in the US and EU: a histo · 5/10 · Drug Development

💡 UNSOLICITED FINDS

PMID42857401 · Current review of glucagon-like peptide 1 receptor agonists and risk of nonarter · 6/10 · Other
PMID42856641 · Epithelial to mesenchymal transition and M2 macrophages drive aggressiveness in · 5/10 · Treatment Innovation

📊 TODAY'S BREAKDOWN

By research category: Diagnostics: 16, Drug Development: 14, Early Detection: 15, Genomics/Precision Medicine: 12, Other: 5, Public Health: 14, Treatment Innovation: 39
By evidence maturity: Exploratory: 105, Validated: 10
By watchlist topic: Hematologic malignancies: raw=72, reviewed=15, high=0, best_score=6/10 CBC-based diagnostics and ML in hematology: raw=1, reviewed=1, high=0, best_score=5/10 Early cancer detection: raw=15, reviewed=15, high=1, best_score=7/10 AI/ML in clinical diagnostics and imaging: raw=49, reviewed=15, high=0, best_score=7/10 Precision oncology and genomic medicine: raw=71, reviewed=15, high=1, best_score=7/10 Novel therapeutics: immunotherapy CAR-T targeted therapy: raw=27, reviewed=15, high=2, best_score=7/10 Cardiovascular-metabolic: GLP-1 SGLT2 cardiometabolic risk: raw=314, reviewed=15, high=0, best_score=7/10 Aging longevity and population health: raw=42, reviewed=15, high=0, best_score=6/10 Rare diseases with high unmet need: raw=32, reviewed=15, high=0, best_score=6/10
By source type: peer_reviewed 110 | preprint 5
Topics with zero 8+ articles this run: Hematologic malignancies, CBC-based diagnostics and ML in hematology, AI/ML in clinical diagnostics and imaging, Cardiovascular-metabolic: GLP-1 SGLT2 cardiometabolic risk, Aging longevity and population health, Rare diseases with high unmet need

🔧 RUN NOTES

Run date: 2026-10-11
Total unique PMIDs fetched: 119
ESummary coverage: 119/119
EFetch coverage: 119/119
9 off-domain false-positive articles reclassified to unsolicited_find